Wide Ranks

CRVO

CervoMed Inc.

9.15

Top Statistics
Market Cap 75 M Forward PE -3.99 Revenue Growth 27.10 %
Current Ratio 15.04 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -118.68 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA Enterprise / Revenue 2.87 Price To Sales Trailing12 Months 7.51
Profitability
Profit Margins -118.68 % Operating Margins -278.19 %
Balance Sheet
Total Cash 46 M Total Cash Per Share 5.65 Total Debt
Total Debt To Equity Current Ratio 15.04 Book Value Per Share 5.53
All Measures
Short Ratio 2204.00 % Message Board Id finmb_280597237 Shares Short Prior Month 1 M
Return On Equity -0.4328 City Boston Uuid c18b10b1-f207-3967-85cb-838eaa2581f8
Previous Close 7.98 First Trade Date Epoch Utc 1 B Book Value 5.53
Volume 586156 Price To Book 1.66 Last Split Date 1 B
Fifty Two Week Low 5.85 Total Cash Per Share 5.65 Total Revenue 10 M
Shares Short Previous Month Date 1 B Target Median Price 55.00 Max Age 86400
Recommendation Mean 1.17 Sand P52 Week Change 0.3133 Operating Margins -278.19 %
Target Mean Price 50.29 Net Income To Common -11947179 Short Percent Of Float 0.3120
Implied Shares Outstanding 8 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 141130 Average Volume10days 141130 Total Cash 46 M
Next Fiscal Year End 1 B Revenue Per Share 1.35 Held Percent Insiders 0.3520
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 7.98 Target Low Price 30.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 12.83 Open 8.54 Free Cashflow -6635316
State MA Dividend Yield 0.00 % Return On Assets -0.2599
Time Zone Short Name EST Trailing Eps -2.17 Day Low 8.26
Address1 20 Park Plaza Shares Outstanding 8 M Price Hint 2
Target High Price 70.00 Website https://www.cervomed.com 52 Week Change -0.0663
Average Volume 94135 Forward Eps -2.54 Recommendation Key strong_buy
Compensation As Of Epoch Date 1 B Quick Ratio 1445.30 % Last Split Factor 2:3
Regular Market Day High 10.29 Is_sp_500 False Profit Margins -118.68 %
Fifty Two Week High 26.38 Day High 10.29 Shares Short 1 M
Regular Market Open 8.54 Industry Key biotechnology Earnings Growth 0.00 %
Enterprise To Revenue 2.87 Revenue Growth 27.10 % Shares Percent Shares Out 0.2022
Operating Cashflow -11018363 Currency USD Time Zone Full Name America/New_York
Market Cap 75 M Is_nasdaq_100 False Zip 02116
Quote Type EQUITY Industry Biotechnology Long Name CervoMed Inc.
Regular Market Day Low 8.26 Held Percent Institutions 0.4271 Current Price 9.15
Address2 Suite 424 Financial Currency USD Current Ratio 15.04
Gross Margins -44.71 % Industry Disp Biotechnology Number Of Analyst Opinions 7
Country United States Float Shares 3 M Two Hundred Day Average 17.10
Enterprise Value 28 M Price To Sales Trailing12 Months 7.51 Forward PE -3.99
Regular Market Volume 586156 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders.

Its lead drug candidate is neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, frontotemporal dementia, and ischemic stroke recovery.

The company also develops EIP200 for central nervous system which is in preclinical trials.

CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.